COLL compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

COLLCollegium Pharmaceutical, Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

COLLCollegium Pharmaceutical, Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

COLLCollegium Pharmaceutical, Inc

23.74▲+0.27%· post 23.75

Mkt cap$770.9MRevenue$200MQ2 FY26Revenue$781MFY25

LLYELI Lilly & Co

1,407.25▼−0.27%· post 1,416.42

ClosedNov 3 '26

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 3 '26

COLLCollegium Pharmaceutical, Inc

LLYELI Lilly & Co

23.74▲+0.27%post 23.75

Price

1,407.25▼−0.27%post 1,416.42

$770.9M

Mkt cap

$1.3T

Q2 FY26$200M

Revenue

$24.4BQ3 FY26

FY25$781M

Revenue

$65.2BFY25

COLL23.74▲+0.27%vsLLY1,407.25▼−0.27%ClosedNov 3 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

COLL: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only COLL 2

—Hikma Pharmaceuticals USAunlistedsupplier

—Grünenthalunlistedsupplier

Shared 0

No shared counterparties.

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

25 more · LLY chain ›

Price

rebased to 0%

COLL, solidLLY, dashed